Previous Close | 1.72 |
1-Year Change | -0.58% |
6-Months Change | -12.69% |
3-Months Change | -26.18% |
Moving Avg (50d) | 1.7812 |
Moving Avg (200d) | 1.9432 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 311.2M |
Beta (3-Years) | 1.82 |
Revenue Growth (ttm) | 3.54% |
Net Profit Margin (ttm) | -42.87% |
Return On Assets (ttm) | -24.19% |
EPS (ttm) | -0.27 |
PE Ratio (ttm) | -6.37 |
Dividend Yield | % |
Asset Description: | Cerus Corporation |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-11-11 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
1.627 | 1.577 | 1.544 | 1.494 | 1.411 | 1.328 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |